Palvella Therapeutics (PVLA) Gross Profit (2013 - 2014)
Palvella Therapeutics (PVLA) reported Gross Profit of $18706.0 for Q3 2014, up 155983.33% year-over-year from N/an in Q3 2013, and up 52061.11% quarter-over-quarter from -$36.0 in Q4 2013.
Palvella Therapeutics (PVLA) Gross Profit (2013 - 2014) Analysis & Trends
Palvella Therapeutics (PVLA) has 2 years of Gross Profit data on file, last reported at $18706.0 in Q3 2014.
- Gross Profit for Q3 2014 came in at $18706.0, up 155983.33% year-over-year; the trailing twelve-month figure through Sep 2014 was $18658.0 (changed N/A YoY), and the FY2013 annual result was $5.2 million, changed N/A from the prior year.
- Gross Profit climbed to $18706.0 in Q3 2014 per PVLA's latest filing, from -$36.0 in the prior quarter.
- Over five years, Gross Profit peaked at $18706.0 in Q3 2014 and troughed at -$36.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 18,706.00 |
| Sep 30, 2014 | 18,706.00 |
| Dec 31, 2013 | -36.00 |
| Dec 31, 2013 | -36.00 |
| Sep 30, 2013 | -12.00 |
| Sep 30, 2013 | -12.00 |